Application for quotation of securities - PER

Aug 14, 2026 at 12:46 AM EDT · Issued by Percheron Therapeutics Limited via ASX

Filed with ASX · Aug 14, 2026 at 12:46 AM EDT

On 6ix: 6ix.com/news/application-for-quotation-of-securities-per-3

Appendix 2A - Application for quotation of securities Appendix 2A - Application for quotation of securities 1 / 6 Announcement Summary Entity name PERCHERON THERAPEUTICS LIMITED Announcement Type New announcement Date of this announcement Friday August 14, 2026 The +securities to be...

View Attachment

6ix hasn’t read this filing yet.

Percheron Therapeutics Limited on 6ix

Earlier from Percheron Therapeutics

Notice of date of AGM and other relevant datesAug 11
Percheron Therapeutics Announces CEO SuccessionAug 9
Quarterly Activities Report and Appendix 4CJul 30
Results of Entitlement OfferApr 14
Prospectus - Non-renounceable Entitlement OfferMar 15

Later from Percheron Therapeutics

Appendix 4E and Annual ReportAug 18
Appendix 4G and Corporate Governance StatementAug 18
Vanderbilt Health to conduct clinical trial of HMBD-002Aug 27
Trading HaltAug 27
Percheron receives $0.70m R&D Tax Incentive RebateAug 30

All Percheron Therapeutics news releases

Follow Percheron Therapeutics into a list and get an email when it puts out news.

Follow Percheron Therapeutics